Global Investor

Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia

Debut, the biotech beauty leader, has secured $20M in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance skin longevity innovation and scale its formulation business in the US and Asia.

Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia Read More »

Hydroleap Secures USD 4.75 million in Latest Funding Round to Accelerate Sustainable Water Technologies in APAC

Singapore – July 30, 2025 – Hydroleap, a pioneering company in sustainable water treatment technologies, has successfully raised an additional USD 4.75 million in its latest funding round from strategic investors including EDBI, which operates under SG Growth Capital – the investment platform of the Singapore Economic Development Board (EDB) and Enterprise Singapore, Antares Ventures and Woh Hup, bringing its total funding to nearly USD 12 million till date.

Hydroleap Secures USD 4.75 million in Latest Funding Round to Accelerate Sustainable Water Technologies in APAC Read More »

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

Augmentus, the developer of an intelligent no-code robotics solution, announced today that it has raised USD $11 million (SGD $14 million) in a Series A+ funding round. The funds will be used to accelerate regional deployment of its fully autonomous robotic surface finishing and welding systems, fulfill demand from marquee manufacturing customers, and advance R&D into hyper-adaptive, AI-driven robotic systems built for the factory floor.

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding Read More »

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management

New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management Read More »

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the successful completion of US$45 million Series B financing.

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy Read More »